Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record.

Serum Tryptase Measurements in Patients with Myelodysplastic Syndromes

Abstract

Abnormal differentiation and maturation of hemopoietic cells are characteristic features of myelodysplastic syndromes (MDS). Tryptases (alpha- and beta-type) are lineage-restricted serine proteases primarily expressed in mast cells (MC). We have analyzed expression of tryptase in 89 de novo MDS patients (refractory anemia (RA), n = 30; RA with ringed sideroblasts (RARS), n = 21; RA with excess of blasts (RAEB/RAEB-t), n = 27; chronic myelomonocytic leukemia (CMML), n = 11). Serum levels of total tryptase (alpha - protryptase + beta - tryptase) were measured by FIA. The numbers of tryptase+ cells were determined in paraffin-embedded bone marrow (bm) sections by immunohistochemistry and morphometry. In healthy individuals, serum total tryptase levels ranged between < 1 and 15 ng/ml (5.6 +/- 2.8 ng/ml). Tryptase levels of > 20 ng/ml were detected in 5/22 patients with RA (22.7%), 4/17 with RARS (23.5%), 0/16 with RAEB/RAEB-t, and 3/8 with CMML (37.5%). Thus, serum tryptase concentrations were higher in RA (16.6 +/- 14.3 ng/ml), RARS (12.9 +/- 8.2), and CMML (16.5 +/- 7.6) compared to RAEB/-t (8.7 +/- 3.8). By morphometry, elevated numbers of tryptase+ bm cells were detected in all MDS groups (RA: 139 +/- 131; RARS: 118 +/- 98; RAEB/RAEB-t: 80 +/- 79; CMML: 105 +/- 114 cells/mm2) compared to controls (54 +/- 51 cells/mm2). As assessed by Northern blotting and protein analysis, bm cells in MDS primarily produced alpha-(pro)tryptase, but little or no beta-tryptase. Together, our data show that elevated levels of tryptase are detectable in a group of patients with MDS probably because of an increase in neoplastic (mast) cells producing the enzyme(s). In addition, serum tryptase levels appear to correlate with MDS variants. Follow up studies should clarify whether an elevated tryptase concentration in MDS is of prognostic significance.

Overview

Integrity signals

Registry

Crossref · 10.1080/10428190290021470

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

2 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Still being checked.

Cited by

See all 83

Metadata

Authors
Sperr, W. R., Stehberger, B., Wimazal, F., Baghestanian, M., Schwartz, L. B., Kundi, M., Semper, H., Jordan, J.-H., Chott, A., Drach, J., Jäger, U., Geissler, K., Greschniok, A., Horny, H.-P., Lechner, K., & Valent, P.
Affiliations
  • University of Vienna (AT)
  • University of Tübingen (DE)
  • Virginia Commonwealth University (US)
Venue
Leukemia & Lymphoma
Published
2002-01
Volume
43
Issue
5
Pages
1097-1105
ISSN
  • 1026-8022 (ISSN-L)
  • 1042-8194
  • 1029-2403
OpenAlex
W1682346499
Cited by
83
References
0
Citations by year
2026: 1 · 2025: 3 · 2024: 8 · 2023: 2 · 2022: 4 · 2021: 3 · 2020: 3 · 2019: 4 · 2017: 1 · 2016: 1 · 2014: 2 · 2013: 2 · 2012: 8
FWCI
2.76
Type
journal article
Language
en
Open access
closed
Locations
  • Leukemia & lymphoma/Leukemia and lymphoma (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Allergy and Infectious Diseases (AI20487)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR45441, R01AR045441)
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Keywords
myelodysplastic syndrome, serum tryptase, beta-tryptase, mast cells, refractory anemia, chronic myelomonocytic leukemia, bone marrow mast cells, serine protease, disease biomarkers, myeloproliferative neoplasms
MeSH terms
Adult, Aged, Aged, 80 and over, Chromosomes, Human, Pair 8, Humans, Middle Aged, Myelodysplastic Syndromes, RNA, Messenger, Serine Endopeptidases, Trisomy, In Situ Hybridization, Fluorescence, Tryptases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum Tryptase Measurements in Patients with Myelodysplastic Syndromes. https://app.cochat.ai/papers/10.1080/10428190290021470
The paper
Sperr, W. R., Stehberger, B., Wimazal, F., Baghestanian, M., Schwartz, L. B., Kundi, M., Semper, H., Jordan, J.-H., Chott, A., Drach, J., Jäger, U., Geissler, K., Greschniok, A., Horny, H.-P., Lechner, K., & Valent, P. (2002). Serum Tryptase Measurements in Patients with Myelodysplastic Syndromes. Leukemia & Lymphoma. https://doi.org/10.1080/10428190290021470

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.